MENU
HCM
AS OF
Feb 4, 03:51 PM (EDT)
Price
$14.76
Change
+$0.37 (+2.57%)
Capitalization
2.54B
22 days until earnings call
Intraday BUY SELL Signals
+Compare
HCM
Stock ticker: NASDAQ
AS OF
Feb 4, 03:51 PM (EDT)
Price
$14.76
Change
+$0.37 (+2.57%)
Capitalization
2.54B

HCM HUTCHMED (China) Limited Forecast, Technical & Fundamental Analysis

HUTCHMED (China) Ltd is an biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases... Show more

HCM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for HCM with price predictions
Feb 03, 2026

HCM's Stochastic Oscillator is staying in oversold zone for 3 days

The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an uptrend is expected.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

HCM moved above its 50-day moving average on January 07, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for HCM crossed bullishly above the 50-day moving average on January 14, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where HCM advanced for three days, in of 266 cases, the price rose further within the following month. The odds of a continued upward trend are .

HCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 192 cases where HCM Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Bearish Trend Analysis

The 10-day RSI Indicator for HCM moved out of overbought territory on January 22, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at .

The Momentum Indicator moved below the 0 level on January 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HCM as a result. In of 87 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for HCM turned negative on January 29, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HCM declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. HCM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.012) is normal, around the industry mean (29.792). P/E Ratio (5.430) is within average values for comparable stocks, (74.095). HCM's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.035). HCM has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.029). P/S Ratio (4.172) is also within normal values, averaging (116.680).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. HCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
HCM
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

HCM is expected to report earnings to rise 2,400.00% to 25 cents per share on February 26

HUTCHMED (China) Limited HCM Stock Earnings Reports
Q4'25
Est.
$0.25
Q4'24
Missed
by $0.03
Q4'23
Beat
by $0.38
Q2'23
Beat
by $1.03
Q4'22
Est.
$-1.02
The last earnings report on March 19 showed earnings per share of 0 cents, missing the estimate of 3 cents. With 5.30K shares outstanding, the current market capitalization sits at 2.54B.
A.I. Advisor
published General Information

General Information

a developer of pharmaceuticals and health oriented consumer products

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
2 Queen's Road Central
Phone
+852 21218200
Employees
1988
Web
https://www.hutch-med.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SSHVX41.620.28
+0.68%
Sound Shore Institutional
UGEIX12.890.07
+0.55%
Victory Global Equity Income
RGLDX28.88-0.26
-0.89%
American Funds Global Insight R-3
RSESX16.87-0.18
-1.06%
Russell Inv US Strategic Equity S
SUSSX16.08-0.20
-1.23%
State Street Instl US Equity Svc

HCM and Stocks

Correlation & Price change

A.I.dvisor tells us that HCM and GELS have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that HCM and GELS's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCM
1D Price
Change %
HCM100%
-1.17%
GELS - HCM
30%
Poorly correlated
-10.05%
ACET - HCM
29%
Poorly correlated
-3.51%
TLRY - HCM
27%
Poorly correlated
+4.57%
CGC - HCM
27%
Poorly correlated
+7.34%
BHC - HCM
26%
Poorly correlated
-1.04%
More

Groups containing HCM

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HCM
1D Price
Change %
HCM100%
-1.17%
Pharmaceuticals: Generic
industry (214 stocks)
14%
Poorly correlated
-0.59%